Patents Assigned to Minoryx Therapeutics S.L.
  • 2,4-Thiazolidinedione Derivatives in the Treatment of Central Nervous System Disorders
    Publication number: 20180133202
    Abstract: The present invention provides 5-(4-(2-(5-(1-hydroxyethyl)pyridine-2-yl)ethoxy)benzyl)thiazolidine-2,4-dione and novel stereoisomers of said compound for use in the treatment of central nervous system (NS) disorders.
    Type: Application
    Filed: October 5, 2017
    Publication date: May 17, 2018
    Applicant: Minoryx Therapeutics S.L.
    Inventors: Ana Maria GARCÍA COLLAZO, David John Augustus Eckland, Maria Pilar Pizcueta Lalanza, Marc Martinell Pedemonte
  • 2,4-thiazolidinedione derivatives in the treatment of central nervous system disorders
    Patent number: 9782395
    Abstract: The present invention provides 5-(4-(2-(5-(1-hydroxyethyl)pyridine-2-yl)ethoxy) benzyl)thiazolidine-2,4-dione and novel stereoisomers of said compound for use in the treatment of central nervous system (NS) disorders.
    Type: Grant
    Filed: May 5, 2016
    Date of Patent: October 10, 2017
    Assignee: MINORYX THERAPEUTICS S.L.
    Inventors: Ana María García Collazo, David John Augustus Eckland, Maria Pilar Pizcueta Lalanza, Marc Martinell Pedemonte
  • 2,4-THIAZOLIDINEDIONE DERIVATIVES IN THE TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS
    Publication number: 20160235729
    Abstract: The present invention provides 5-(4-(2-(5-(1-hydroxyethyl)pyridine-2-yl)ethoxy) benzyl)thiazolidine-2,4-dione and novel stereoisomers of said compound for use in the treatment of central nervous system (NS) disorders.
    Type: Application
    Filed: May 5, 2016
    Publication date: August 18, 2016
    Applicant: MINORYX THERAPEUTICS S.L.
    Inventors: Ana Maria Garcia Collazo, David John Augustus Eckland, Maria Pilar Pizcueta Lalanza, Marc Martinell Pedemonte
  • DI(HETERO)ARYLAMIDES AND SULFONAMIDES, METHODS FOR THEIR PREPARATION AND THERAPEUTIC USES THEREOF
    Publication number: 20160168132
    Abstract: The present invention refers to compounds of formula (I): as well as to a method for their preparation, pharmaceutical compositions comprising the same, and use thereof for the treatment and/or prevention of conditions associated with the alteration of the activity of ?-galactosidase, specially galactosidase beta-1 or GLB1, including GM1 gangliosidoses and Morquio syndrome, type B.
    Type: Application
    Filed: July 30, 2014
    Publication date: June 16, 2016
    Applicant: Minoryx Therapeutics S.L.
    Inventors: Xavier BARRIL ALONSO, Ana Maria GARCÍA COLLAZO, Juan AYMAMI BOFARULL, Marc REVÉS VILAPLANA, Rodolfo LAVILLA GRIFOLS, Marc MARTINELL PEDEMONTE